Rizzoni Damiano, Agabiti-Rosei Claudia, De Ciuceis Carolina
Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Division of Medicine, Spedali Civili di Brescia, Montichiari (Brescia), Italy.
Am J Hypertens. 2023 Jan 1;36(1):1-13. doi: 10.1093/ajh/hpac093.
Although the gold-standard method for the assessment of structural alteration in small resistance arteries is the evaluation of the MLR by micromyography in bioptic tissues, new, noninvasive techniques are presently under development, focusing mainly on the evaluation of WLR in retinal arterioles. These approaches represent a promising and interesting future perspective. Appropriate antihypertensive treatment is able to prevent the development of microvascular alterations or to induce their regression. Also, conductance arteries may be affected by a remodeling process in hypertension, and a cross-talk may exist between structural changes in the small and large arteries. In conclusion, the evaluation of microvascular structure is ready for clinical prime time, and it could, in the future, represent an evaluation to be performed in the majority of hypertensive patients, to better stratify cardiovascular risk and better evaluate the effects of antihypertensive therapy. However, for this purpose, we need a clear demonstration of the prognostic relevance of noninvasive measures of microvascular structure, in basal conditions and during treatment. Vascular remodeling may be frequently observed in hypertension, as well as in obesity and diabetes mellitus. An increased media to lumen ratio (MLR) or wall to lumen ratio (WLR) in microvessels is the hallmark of hypertension, and may impair organ flow reserve, being relevant in the maintenance and, probably, also in the progressive worsening of hypertensive disease, as well as in the development of hypertension-mediated organ damage/cardiovascular events. The molecular mechanisms underlying the development of vascular remodeling are only partly understood.
虽然评估小阻力动脉结构改变的金标准方法是通过对活检组织进行微血管描记术来评估肌层厚度比(MLR),但目前新的非侵入性技术正在研发中,主要聚焦于评估视网膜小动脉的壁腔比(WLR)。这些方法代表了一个有前景且有趣的未来方向。适当的降压治疗能够预防微血管改变的发生或促使其逆转。此外,传导动脉在高血压中可能会受到重塑过程的影响,小动脉和大动脉的结构变化之间可能存在相互作用。总之,微血管结构的评估已准备好进入临床应用阶段,未来它可能成为大多数高血压患者都要进行的一项评估,以更好地分层心血管风险并更好地评估降压治疗的效果。然而,为此我们需要明确证明在基础状态和治疗期间微血管结构的非侵入性测量方法的预后相关性。血管重塑在高血压以及肥胖和糖尿病中经常可见。微血管中增加的中膜与管腔比值(MLR)或壁与管腔比值(WLR)是高血压的标志,可能会损害器官血流储备,与高血压疾病的维持以及可能的逐渐恶化相关,也与高血压介导的器官损害/心血管事件的发生有关。血管重塑发生的分子机制仅得到部分理解。